IL6 and colorectal carcinoma: In vitro experiments further demonstrated that recombinant IL-6 at concentrations of 10 and 100 pg/mL could inhibit human CRC cell proliferation and reduce γ-H2AX expression, reflecting the anti-cancer properties associated with exercise.